Valuation Lamdong Pharmaceutical

Stocks

End-of-day quote HANOI S.E. 2026-10-01			5-day change	1st Jan Change
7,700.00 ^VND	0.00%		-1.28%	-30.63%

07-27	Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
04-23	Lamdong Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2023	2024	2025
Market Cap ¹	201,980	129,572	148,053
Change	-	-35.85%	14.26%
Enterprise Value (EV) ¹	247,718	167,441	184,198
Change	-	-32.41%	10.01%
P/E	-10x	18.7x	5.47x
PBR	2.19x	1.31x	1.09x
PEG	-	-0x	0x
Capitalization / Revenue	1.09x	0.59x	0.61x
EV / Revenue	1.33x	0.77x	0.76x
EV / EBITDA	-60.3x	8.33x	7.97x
EV / EBIT	-20.1x	12.6x	10.5x
EV / FCF	29.8x	29x	-1.39x
FCF Yield	3.36%	3.44%	-72%
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-1,583	545	2,030
Distribution rate	-	-	-
Net sales ¹	186,001	217,958	243,906
EBITDA ¹	-4,110	20,093	23,115
EBIT ¹	-12,347	13,280	17,460
Net income ¹	-20,105	6,919	28,558
Net Debt ¹	45,738	37,869	36,145
Reference price ²	15,900.00	10,200.00	11,100.00
Nbr of stocks (in thousands)	12,703	12,703	13,338
Announcement Date	4/2/25	4/2/25	4/7/26

¹VND in Million²VND

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LAMDONG PHARMACEUTICAL	-	-	-	-	5.55M
ELI LILLY AND COMPANY	32.69x	11.85x	24.08x	0.6%	1,025B
JOHNSON & JOHNSON	28.77x	6.4x	17.91x	2.06%	623B
ABBVIE INC.	32.89x	7.71x	15.93x	2.67%	459B
MERCK & CO., INC.	104.62x	5.85x	24.82x	2.37%	355B
ROCHE HOLDING AG	18.99x	4.63x	11.47x	2.87%	336B
NOVARTIS AG	20.13x	5.23x	12.95x	3.06%	270B
ASTRAZENECA PLC	20.27x	4.21x	12x	2.1%	247B
AMGEN INC.	25.72x	6.72x	11.97x	2.48%	220B
GILEAD SCIENCES, INC.	-44.61x	6.5x	25.4x	2.23%	183B
Average	26.61x	6.57x	17.39x	2.27%	371.82B
Weighted average by Cap.	31.73x	7.64x	18.71x	1.95%